What Part of the Body Itches With Liver Problems?

Liver-related itching concentrates most intensely on the palms of the hands and the soles of the feet, though it frequently spreads to the limbs and can eventually become generalized across the whole body. Unlike a rash or allergic reaction, this kind of itch usually shows no visible skin changes at all, which is part of what makes it so confusing and frustrating for the people who experience it. The underlying cause, the pattern of where it strikes, and the reason it torments people most at night all trace back to how bile and other substances build up when the liver’s drainage system malfunctions.

Palms, Soles, and Limbs Are the Classic Targets

When doctors evaluate itching linked to liver disease, they look for a recognizable distribution pattern. The itch tends to start on or be most severe on the palms and soles, then extend to the arms and legs more broadly. In many cases it eventually becomes widespread, but even when the whole body itches, the palms and soles remain the worst spots. This distribution is distinctive enough that clinicians use it as a diagnostic clue to separate liver itch from other causes of chronic itching.¹

One reason this pattern stands out is that most dermatological conditions produce their worst itching wherever a rash appears, and rashes on the palms and soles are uncommon outside of a few specific diseases. With liver itch, there is typically no rash, no bumps, no redness, and no hives at the site that itches. The only visible evidence is scratch marks left behind from the patient trying to get relief.¹ That absence of a primary skin lesion is one of the strongest signals pointing toward the liver rather than the skin as the source of the problem.

Why There Is No Rash

The lack of visible skin changes is not a coincidence. Itch in liver disease is generated internally. It originates from substances circulating in the bloodstream and from signals processed in the nervous system, not from inflammation or immune activity in the skin itself. This puts it in a different category from conditions like eczema, psoriasis, or hives, where the itch is a direct result of something going wrong at the skin surface. The clinical term for this internal-origin itch is cholestatic pruritus, reflecting the bile-flow problem (cholestasis) that triggers it.²

Because the itch has no visible cause, patients frequently go undiagnosed or get treated for skin conditions they don’t actually have. Antihistamines, which work for hives and allergies, are largely ineffective against liver itch because histamine is not the primary driver. If you’ve been dealing with intense, unexplained itching on your palms, soles, or limbs and standard itch treatments aren’t helping, that pattern itself is worth mentioning to your doctor.

The Nighttime Problem

Liver itch doesn’t stay constant throughout the day. Roughly two-thirds of people with cholestatic itch report that it gets worse at night, and a similar proportion find that heat makes it worse while cool temperatures provide some relief.³ This nighttime worsening is significant because it devastates sleep quality. Patients with liver disease and pruritus report worse sleep timing, more frequent awakenings, and profound daytime fatigue compared to patients with the same liver conditions who don’t itch.⁴

The nighttime pattern likely relates to several factors. Circulating bile acid levels follow their own daily rhythms, and body temperature rises slightly during evening hours, which can intensify the sensation. Cortisol levels also drop at night, and cortisol has some anti-itch properties. The practical takeaway is that keeping your sleeping environment cool, using light breathable fabrics, and avoiding hot baths before bed can take the edge off, even though these measures won’t eliminate the itch entirely.

What Is Actually Causing the Itch

For decades, researchers assumed bile acids were the sole culprit. When the liver can’t drain bile properly, bile acids accumulate in the blood and deposit in tissues, including the skin. And bile acids do play a role. Scientists have identified a receptor on human sensory nerve cells called MRGPRX4 that responds directly to bile acids at the concentrations found in cholestatic patients, essentially proving that bile acids can activate itch-sensing neurons.⁵ More recent structural work has confirmed this receptor as a key link between circulating bile acids and the sensation of itching.⁶

But bile acids alone don’t explain everything. Some patients itch terribly while their bile acid levels are only mildly elevated, and some have sky-high bile acids with minimal itch. This mismatch led researchers to look for other mediators, and the most compelling one turned out to be a substance called lysophosphatidic acid, or LPA. LPA is produced by an enzyme called autotaxin, and autotaxin levels in the blood turn out to correlate with itch intensity far more reliably than bile acid levels do.⁷ Autotaxin activity is specifically elevated in cholestatic itch but not in itch from other causes, and it drops when treatments successfully relieve the itching.⁸

A third contributor involves the body’s own opioid system. People with cholestatic liver disease appear to have altered levels of endogenous opioids, and there is evidence that these changes contribute to the itch sensation through effects on the brain rather than the skin.⁹ Medications that block opioid receptors can improve the itching, which supports this theory, though the relationship isn’t straightforward. One study found that patients with cholestatic itch actually had lower levels of certain endogenous opioids rather than the expected higher levels, and opioid levels didn’t correlate with how bad the itch felt.¹⁰ The opioid contribution appears to be real but is clearly more complex than early models assumed.

Which Liver Conditions Cause the Worst Itching

Not all liver problems produce itch with the same frequency or severity. The conditions most strongly associated with debilitating pruritus are the cholestatic liver diseases, where bile flow is physically obstructed or impaired. Primary biliary cholangitis (PBC) and primary sclerosing cholangitis (PSC) are the two most prominent. In a large survey of PSC patients, 91% reported experiencing pruritus at some point, with about a third actively itching at the time they were surveyed. Nearly half of those with active itch said the episodes lasted a month or longer, and half reported that the itch disrupted their daily activities.¹¹

PBC patients face a similar burden, with the added finding that those who itch have significantly higher rates of depression, anxiety, fatigue, and sleep problems compared to PBC patients who don’t itch and to the general population.¹² Fatigue was roughly twice as common in PBC patients with itch compared to matched controls without PBC. The itch doesn’t just make people uncomfortable; it drives a cascade of secondary health problems.

Chronic viral hepatitis, particularly hepatitis C, can also produce significant itching. Hepatitis C is associated with various skin-related complications, and the bile acid buildup from progressive liver damage is considered a primary driver of the pruritus these patients experience.¹³ Drug-induced liver injury can produce cholestatic itch as well, though this tends to resolve if the offending medication is identified and stopped.

Itching During Pregnancy

Intrahepatic cholestasis of pregnancy (ICP) deserves its own discussion because it follows the same palm-and-sole pattern described above, it often strikes women with no prior liver problems, and it carries risks for the baby. The itch typically begins on the palms and soles before potentially spreading more widely, and it characteristically worsens at night. In ICP, the itching tends to appear before blood tests show any abnormalities, which means a pregnant woman’s complaint of intense, unexplained palm and sole itching should be taken seriously even if initial lab work looks normal.

Estrogen plays a direct role. Elevated estrogen levels during pregnancy can reduce bile flow and trigger toxic accumulation of bile acids, and women with a genetic susceptibility to cholestasis are more vulnerable to this effect.¹⁴ The same mechanism can cause cholestasis in women taking oral contraceptives or postmenopausal hormone therapy, though the incidence is lower outside pregnancy. If you experienced ICP during one pregnancy, you’re at increased risk during subsequent pregnancies and may also be more sensitive to estrogen-containing medications later in life.

How Liver Itch Is Treated

Treatment follows a stepwise approach that reflects the multifactorial nature of the itch. The first-line medication is cholestyramine, a bile acid sequestrant that binds bile acids in the gut and prevents their reabsorption. If cholestyramine doesn’t provide adequate relief, the next step is rifampicin, an antibiotic that also has itch-reducing properties through effects on bile acid metabolism. If rifampicin fails or can’t be tolerated, opioid antagonists like naltrexone are tried, followed by sertraline, an antidepressant that appears to have some anti-itch activity independent of its mood effects.¹⁵

Each step has trade-offs. Cholestyramine tastes unpleasant and causes gastrointestinal side effects, and it must be taken at least four hours apart from other medications because it interferes with their absorption. Rifampicin requires liver function monitoring because it can, paradoxically, cause liver damage in a small percentage of patients. Naltrexone can trigger an opioid withdrawal-like reaction in the first days of use, even in people who have never taken opioid medications, because it blocks the endogenous opioids that cholestatic patients have adapted to.¹⁶ Naltrexone’s ability to improve subjective sleep quality is a meaningful bonus for patients whose itch primarily disrupts their nights.⁴

For patients who fail the standard ladder, a few other options exist. UVB phototherapy showed strong results in a case series: 10 of 13 patients achieved more than 60% reduction in itch severity, with median itch scores dropping from 8 out of 10 to 2 out of 10.¹⁷ Plasmapheresis, a procedure that filters the blood to remove circulating itch mediators, has been used successfully in treatment-resistant cases and can serve as a bridge to liver transplantation when other options have been exhausted.¹⁸ Liver transplantation itself, when indicated for the underlying disease, typically resolves the itching entirely.

Telling Liver Itch Apart From Skin Conditions

Because liver itch doesn’t look like anything on the skin surface, distinguishing it from other causes of generalized itching can be tricky. A few features help. Eczema and contact dermatitis produce visible rashes, redness, and textural changes. Scabies causes tiny burrows and tends to concentrate in the web spaces of the fingers, the wrists, and the groin. Psoriasis creates thick, scaly plaques. Drug reactions often produce widespread hives. Liver itch, by contrast, produces clean-looking skin with nothing to see except scratch marks, and it has that characteristic affinity for the palms and soles that most dermatological itch does not share.¹

A blood test checking liver enzymes and bile acid levels is the fastest way to confirm or rule out a hepatic cause. Alkaline phosphatase and gamma-glutamyl transferase tend to be elevated in cholestatic conditions, and serum bile acids are the most specific marker for cholestasis-related itch. If your doctor suspects ICP during pregnancy, bile acid levels are the critical test, though they can lag behind the onset of itching by days or even weeks.

The Psychological Weight of Chronic Itch

The burden of liver-related itching goes well beyond a physical sensation. Chronic unrelenting itch is one of the most psychologically distressing symptoms in medicine, and the data bears this out. Among PBC patients with pruritus, rates of depression and anxiety are substantially higher than in PBC patients without itch, and the fatigue that comes with disrupted sleep compounds both the physical and emotional toll.¹² PSC patients tell a similar story, with half of those experiencing itch saying it disrupts their daily activities.¹¹

Clinicians now use validated rating scales to track itch severity and its effects on sleep and fatigue over time, which helps them gauge whether treatments are working and when to escalate to the next step.¹⁹ If you’re living with liver itch and feel like your complaints aren’t being taken seriously, asking your doctor to formally assess itch severity and its impact on your sleep can help move the conversation toward more aggressive treatment. This isn’t a symptom anyone should be told to simply tolerate.

New Research on Itch Receptors

The discovery of MRGPRX4 as the receptor through which bile acids trigger itch neurons has opened a new avenue for drug development. Researchers recently solved the three-dimensional structure of this receptor while it was bound to bile acids, which is the kind of detailed blueprint that pharmaceutical companies use to design targeted drugs.⁶ The same study identified a way to design liver-targeted drugs that activate beneficial bile acid receptors inside the liver without triggering the itch receptor on nerve cells. This could eventually allow treatment of cholestatic liver disease without the side effect of worsened itching, a problem that has plagued some existing therapies.

Autotaxin inhibitors are another area of active investigation. Because autotaxin activity tracks so closely with itch severity and responds to successful treatment, it represents both a potential drug target and a useful biomarker for clinical trials.⁸ Several compounds designed to block autotaxin are in various stages of clinical testing. If they prove effective, they would represent the first treatments designed specifically for cholestatic itch rather than repurposed from other conditions, which is essentially what every current therapy in the stepwise ladder is.

1
PubMed Central. Itch and liver: management in primary care
2
PubMed Central. Cholestatic pruritus: Emerging mechanisms and therapeutics
3
Acta Dermato-Venereologica. Itch in Primary Biliary Cirrhosis: A Patients’ Perspective
4
PubMed Central. Sleep disorder in patients with chronic liver disease: a narrative review
5
PubMed Central. MRGPRX4 is a G protein-coupled receptor activated by bile acids that may contribute to cholestatic pruritus
6
Cell. Structural basis of human cholestatic itch and discovery of a non-pruritic FXR agonist
7
Gastroenterology. Lysophosphatidic Acid Is a Potential Mediator of Cholestatic Pruritus
8
PubMed. Serum autotaxin is increased in pruritus of cholestasis, but not of other origin, and responds to therapeutic interventions
9
PubMed. Pruritus and fatigue in primary biliary cirrhosis
10
PubMed Central. Endogenous Opioid Levels Do Not Correlate With Itch Intensity and Therapeutic Interventions in Hepatic Pruritus
11
Hepatology Communications. A multinational survey assessing the impact and burden of pruritus on patients with primary sclerosing cholangitis
12
BMJ Open Gastroenterology. Disease burden of primary biliary cholangitis and associated pruritus based on a cross-sectional US claims analysis
13
PubMed Central. Hepatitis C virus-associated pruritus: Etiopathogenesis and therapeutic strategies
14
PubMed Central. The Pathological Mechanisms of Estrogen-Induced Cholestasis: Current Perspectives
15
PubMed. Management of Chronic Hepatic Itch
16
PubMed. Cholestasis and endogenous opioids: liver disease and exogenous opioid pharmacokinetics
17
PubMed. Cholestasis-induced pruritus treated with ultraviolet B phototherapy: an observational case series study
18
PubMed. Plasmapheresis can improve clinical outcomes in patients with therapy resistant benign recurrent intrahepatic cholestasis: A case report
19
PubMed Central. Psychometric validation of the Worst Itch Numerical Rating Scale (WI-NRS) and other patient-reported outcome measures for assessing severity and impact of pruritus in patients with primary biliary cholangitis